|
|
Advisors
Aileron's scientific advisors include a powerful set of industry leaders who have the critical expertise across all facets of peptide drug science and technology.
- Gregory L. Verdine, Ph.D.
- Co-Chairman, Scientific Advisory Board
Harvard College Professor, Erving Professor of Chemistry, Department of Chemistry and Chemical Biology, Harvard University; and Director, Chemical Biology Initiative and Program in Cancer Chemical Biology, Dana-Farber Cancer Institute
- Loren D. Walensky, M.D., Ph.D.
- Scientific Advisory Board Member
Assistant Professor of Pediatrics; Medical Director, Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School
- Elliot Ehrich, M.D.
- Scientific Advisory Board Member
Senior Vice President, Research & Development, and Chief Medical Officer, Alkermes Inc.
- Victor J. Hruby, Ph.D.
- Scientific Advisor
Regents Professor Emeritus of Chemistry, University of Arizona; Hirschmann Award Winner; Merrifield Award Winner; Arthur C. Cope Scholar Award Winner
- Michael B. Kastan, M.D., Ph.D.
- Scientific Advisory Board Member
Director of the Cancer Center, Director of the Molecular Therapeutics Division and Co-Director of the Molecular Oncology Program, St. Jude Children's Research Hospital
- David G. Nathan, M. D.
- Scientific Advisory Board Member
President Emeritus, Dana-Farber Cancer Institute. Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School
- Daniel F. Veber, Ph.D.
- Scientific Advisor
Former Director of Medicinal Chemistry, GlaxoSmithKline; Former Senior Director of Medicinal Chemistry, Merck; Hirschmann Award Winner; Merrifield Award Winner
|
